To bring cutting-edge diagnostic platforms to clinical use, Roche introduced the AXELIOS sequencing-by-expansion (SBX) ...

Eight months after more than doubling down on its construction of a $2 billion drug manufacturing facility in Holly Springs, North Carolina, Roche is making a similar move on the other side of the ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.

INDIANAPOLIS, July 22, 2026 /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, Roche will showcase integrated ...

Roche announced that it introduces the cobas HDV test for use on the cobas 5800/6800/8800 systems, a diagnostic tool for the detection and quantification of Hepatitis D Virus (HDV) RNA, in countries ...

The new $6,000 senior deduction accelerates Social Security's trust fund insolvency to 2032, threatening a 22% cut worth $456 monthly for average recipients. Karen Glenn projects the OBBBA raises ...

It’s the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster. Pharmaceutical giant Roche said today it is launching a new large-scale “AI factory ...

Pharmaceutical and diagnostics giant Roche announced it will fund a $550 million diagnostic center in Indianapolis by 2030. The manufacturing hub will produce Roche's continuous glucose monitoring ...

Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit the Swiss pharma bought for $4.3 billion in 2019. Roche described the restructuring in its ...

Roche has begun rolling out a new diagnostics system that aims to bring the gold-standard accuracy of mass spectrometry to the everyday clinical lab. The company received a CE Mark approval in Europe ...

Roche AG’s new test using its temperature-activated generation of signal technology is the next step in PCR evolution, Igor Kozlov, head of Reagent Research and Design at Roche Diagnostics Solutions, ...